- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jiangsu Hengrui Medicine Co Ltd (600276)
Jiangsu Hengrui Medicine Co Ltd stock price live, this page displays SS 600276 stock exchange data. View the 600276 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jiangsu Hengrui Medicine Co Ltd real time stock price chart below.
What Is the Jiangsu Hengrui Medicine Co Ltd Stock Price Today?
The Jiangsu Hengrui Medicine Co Ltd stock price today is 43.16.
What Is the Stock Symbol for Jiangsu Hengrui Medicine Co Ltd?
The stock symbol for Jiangsu Hengrui Medicine Co Ltd is "600276."
What Stock Exchange Does Jiangsu Hengrui Medicine Co Ltd Trade On?
Jiangsu Hengrui Medicine Co Ltd is listed and trades on the Shanghai stock exchange.
Is Jiangsu Hengrui Medicine Co Ltd a Good Stock to Buy?
Determining whether Jiangsu Hengrui Medicine Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600276 quote. (ISIN: CNE0000014W7)
What Is the Jiangsu Hengrui Medicine Co Ltd Stock Price Today?
The Jiangsu Hengrui Medicine Co Ltd stock price today is 43.16.
What Is the Stock Symbol for Jiangsu Hengrui Medicine Co Ltd?
The stock symbol for Jiangsu Hengrui Medicine Co Ltd is "600276."
What Stock Exchange Does Jiangsu Hengrui Medicine Co Ltd Trade On?
Jiangsu Hengrui Medicine Co Ltd is listed and trades on the Shanghai stock exchange.
Is Jiangsu Hengrui Medicine Co Ltd a Good Stock to Buy?
Determining whether Jiangsu Hengrui Medicine Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 600276 quote. (ISIN: CNE0000014W7)
43.16
+0.01(+0.02%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.99
43.49
52 wk Range
41.89
73.12
600276 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.9943.49
52 wk Range
41.8973.12
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.47%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.47%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600276 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
71.35
Upside
+65.33%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Hengrui Medi receives Investment Bank Analyst Rating Update- Investing.com
Pro
Hengrui Medi receives Investment Bank Analyst Rating Update- Investing.com
Pro
Hengrui Medi receives Investment Bank Analyst Rating Update- Investing.com
Pro
Hengrui Medi receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Hengrui Medi receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Hengrui Medi receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Hengrui Medi receives Investment Bank Analyst Rating Update- Investing.com
Pro- Hengrui Medi receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
19 Buy
0 Hold
0 Sell
Ratings:
19 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 71.35
(+65.33% Upside)
Earnings
Latest Release
Aug 19, 2026
EPS / Forecast
0.34 / 0.38
Revenue / Forecast
7.32B / 9.02B
Compare 600276 to Peers and Sector
Metrics to compare | 600276 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600276PeersSector | |
|---|---|---|---|---|
P/E Ratio | 36.9x | 15.4x | −0.4x | |
PEG Ratio | - | 0.33 | 0.00 | |
Price/Book | 4.4x | 2.0x | 2.6x | |
Price / LTM Sales | 9.1x | 1.7x | 3.0x | |
Upside (Analyst Target) | 67.2% | 33.7% | 54.5% | |
Fair Value Upside | Unlock | 24.8% | 7.8% | Unlock |
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Jiangsu Hengrui (600276) Stock Price Today?
The Jiangsu Hengrui stock price today is 43.16 CNY.
What Stock Exchange Does Jiangsu Hengrui Trade On?
Jiangsu Hengrui is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Jiangsu Hengrui?
The stock symbol for Jiangsu Hengrui is "600276."
Does Jiangsu Hengrui Pay Dividends? What’s The Current Dividend Yield?
The Jiangsu Hengrui dividend yield is 0.47%.
What Is the Jiangsu Hengrui Market Cap?
As of today, Jiangsu Hengrui market cap is 286.23B CNY.
What Is Jiangsu Hengrui's Earnings Per Share (TTM)?
The Jiangsu Hengrui EPS (TTM) is 1.16.
When Is the Next Jiangsu Hengrui Earnings Date?
Jiangsu Hengrui will release its next earnings report on Oct 23, 2026.
From a Technical Analysis Perspective, Is 600276 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Jiangsu Hengrui Stock Split?
Jiangsu Hengrui has split 19 times.
How Many Employees Does Jiangsu Hengrui Have?
Jiangsu Hengrui has 20602 employees.
What is the current trading status of Jiangsu Hengrui (600276)?
As of Sep 15, 2026, Jiangsu Hengrui (600276) is trading at a price of 43.16 CNY, with a previous close of 43.15 CNY. The stock has fluctuated within a day range of 42.99 CNY to 43.49 CNY, while its 52-week range spans from 41.89 CNY to 73.12 CNY.
What Is Jiangsu Hengrui (600276) Price Target According to Analysts?
The average 12-month price target for Jiangsu Hengrui is 71.35 CNY, with a high estimate of 109 CNY and a low estimate of 50 CNY. 19 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +65.33% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.